The aim of this study was to analyze characteristics associated with noncompliance
with lipid-lowering guidelines among patients with coronary heart disease (CHD). More
specifically, we analyzed failure to initiate lipid-lowering treatment in patients
with CHD and low-density lipoprotein (LDL) cholesterol >130 mg/dl (3.37 mmol/L).
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).JAMA. 2001; 285: 2486-2497
- Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease.Am J Cardiol. 1999; 83: 1303-1307
Article info
Publication history
Accepted:
February 12,
2003
Received in revised form:
February 12,
2003
Received:
January 24,
2003
Footnotes
This study was funded by a V.A. HSR&D Grant # IHD 98-001 from the V.A. Quality Enhancement Research Initiative (QUERI) Ischemic Heart Disease (IHD-QUERI) Coordinating Center, Seattle, Washington.
Identification
Copyright
© 2003 Excerpta Medica Inc. Published by Elsevier Inc. All rights reserved.
